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Abstract
Background: Recent meta-analysis of genome-wide association studies in European descent samples identified novel loci
influencing glucose and insulin related traits. In the current study, we aimed to evaluate the association between these loci
and traits related to glucose metabolism in the Chinese.
Methods/Principal Findings: We genotyped seventeen single nucleotide polymorphisms (SNPs) from fifteen loci including
GIPR, ADCY5, TCF7L2, VPS13C, DGKB, MADD, ADRA2A, FADS1, CRY2, SLC2A2, GLIS3, PROX1, C2CD4B, SLC30A8 and IGF1 in 6,822
Shanghai Chinese Hans comprising 3,410 type 2 diabetic patients and 3,412 normal glucose regulation subjects. MADD
rs7944584 showed strong association to type 2 diabetes (p=3.5610
26, empirical p=0.0002) which was not observed in the
European descent populations. SNPs from GIPR, TCF7L2, CRY2, GLIS3 and SLC30A8 were also associated with type 2 diabetes
(p=0.0487,2.0610
28). Further adjusting age, gender and BMI as confounders found PROX1 rs340874 was associated with
type 2 diabetes (p=0.0391). SNPs from DGKB, MADD and SLC30A8 were associated with fasting glucose while PROX1
rs340874 was significantly associated with OGTT 2-h glucose (p=0.0392,0.0014, adjusted for age, gender and BMI), the
glucose-raising allele also showed association to lower insulin secretion. IGF1 rs35767 showed significant association to both
fasting and 2-h insulin levels as well as insulin secretion and sensitivity indices (p=0.0160,0.0035, adjusted for age, gender
and BMI).
Conclusions/Significance: Our results indicated that SNPs from GIPR, TCF7L2, DGKB, MADD, CRY2, GLIS3, PROX1, SLC30A8
and IGF1 were associated with traits related to glucose metabolism in the Chinese population.
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Introduction
Diabetes is one of the major health problems worldwide.
According to the results of China National Diabetes and
Metabolic Disorders Study, the prevalences of total diabetes and
prediabetes in China were 9.7% and 15.5%, respectively [1]. Over
90% of the Chinese diabetes patients are type 2 diabetes. Type 2
diabetes is a metabolic disorder characterized by chronic
hyperglycemia in the context of insulin resistance and relative
insulin deficiency [2]. Although Western lifestyle contributes a lot
to the type 2 diabetes epidemic, genetic determinants also
influence type 2 diabetes susceptibility. Nowadays, multiple genes
were identified to influence type 2 diabetes susceptibility, fasting
and postprandial glucose levels [3,4,5,6]. Recent reports on meta-
analysis of genome-wide association studies focusing on glucose
and insulin related traits identified nine novel fasting glucose loci
(ADCY5, MADD, ADRA2A, CRY2, FADS1, GLIS3, SLC2A2, PROX1
and C2CD4B), five oral glucose tolerance tests (OGTTs) 2-h
glucose loci (GIPR, ADCY5, VPS13C, GCKR and TCF7L2) and one
locus (IGF1) associated with fasting insulin levels and insulin
resistance [7,8]. Besides, the effects of previous reported type 2
diabetes and/or fasting glucose loci G6PC2, GCK, GCKR,
MTNR1B, DGKB, SLC30A8 and TCF7L2 were also replicated in
the meta-analysis [7,8]. However, as the initial studies were
performed in the European descent adults, replication studies in
other ethnic samples are important to fully understand their effects
on disease susceptibility. Among these loci, only the effects of GCK,
GCKR, G6PC2 and MTNR1B on fasting glucose levels and beta cell
function had been well validated in multiple populations
[9,10,11,12,13,14], while the effects of the other loci on fasting
and 2-h glucose in non-European descent populations remained
largely unknown. The effects of these novel loci on type 2 diabetes
risk were also unclear. In the present study, we aimed to test for
the association of SNPs from fifteen reported loci and type 2
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metabolism in the case-control samples of Shanghai Chinese.
Methods
Ethics statement
This study was approved by the institutional review board of
Shanghai Jiao Tong University Affiliated Sixth People’s
Hospital in accordance with the principle of the Helsinki
Declaration II. Written informed consent was obtained from
each participant.
Participants
We recruited a total of 6,822 participants of Chinese Han
ancestry residing in Shanghai, comprising 3,410 type 2 diabetes
patients and 3,412 controls. All cases were unrelated type 2
diabetes patients recruited from the inpatient database of
Shanghai Diabetes Institute. The controls were subjects with
normal glucose tolerance as assessed by standard 75 g OGTTs,
and with negative family history of diabetes that recruited from
Shanghai Diabetes Study [15] and Shanghai Diabetes Study II
[16]. The clinical characteristics of the cases and controls were
shown in Table 1.
Clinical measurements
Phenotypes for anthropometric and biochemical traits related to
glucose metabolism were extensively measured for both case and
control subjects. OGTTs were performed in the controls in the
morning after an overnight fast. Blood samples were obtained at
the fasting and 2 h during OGTTs. Plasma glucose and serum
insulin were measured. Basal insulin sensitivity and beta cell
function were calculated from fasting plasma glucose and insulin
using HOMA [17]. In addition, insulin secretion and sensitivity
were also estimated according to the indices proposed by Stumvoll
et al [18] and Gutt et al [19].
SNP selection, genotyping and quality control analysis
We selected seventeen SNPs from fifteen loci (GIPR rs10423928,
ADCY5 rs2877716 and rs11708067, TCF7L2 rs12243326 and
rs4506565, VPS13C rs17271305, DGKB rs2191349, MADD
rs7944584, ADRA2A rs10885122, FADS1 rs174550, CRY2
rs11605924, SLC2A2 rs11920090, GLIS3 rs7034200, PROX1
rs340874, C2CD4B rs11071657, SLC30A8 rs11558471, and IGF1
Table 1. Clinical characteristics of the study samples.
Cases Controls
Samples (n) 3,410 3,412
Male/female (n) 1,871/1,589 1,364/2,048
Age (years) 60.33612.49 50.10614.27
BMI (kg/m
2) 24.3863.51 23.4663.25
Fasting glucose (mmol/l) - 5.0260.50
2-h glucose (mmol/l) - 5.4661.13
Fasting insulin (mmol/l) - 37.02(26.04, 51.84)
2-h insulin (mmol/l) - 168.03(92.16, 279.84)
HOMA-B - 89.87(62.63, 135.84)
HOMA-IR - 1.33(0.93, 1.90)
Data are shown as mean6SD, median (interquartile range) or n.
doi:10.1371/journal.pone.0015542.t001
Table 2. Effects of SNPs from fifteen glucose and insulin loci on type 2 diabetes susceptibility in the Chinese population.
Risk allele
frequency
SNP Gene
Risk/non-risk
allele Cases Controls OR(95%CI) P value
Empirical
P value OR(95%CI)
# P value
#
Empirical
P value
#
rs10423928 GIPR A*/T 0.1981 0.1838 1.097(1.005–1.197) 0.0378 0.4718 1.100(1.002–1.208) 0.0462 0.5638
rs2877716 ADCY5 C*/T 0.9978 0.9976 1.060(0.524–2.145) 0.8717 1 1.055(0.484–2.296) 0.8932 1
rs11708067 ADCY5 A*/G 0.9981 0.9973 1.376(0.673–2.810) 0.3794 0.9997 1.386(0.654–2.934) 0.3940 0.9998
rs12243326 TCF7L2 C*/T 0.0048 0.0027 1.778(0.990–3.192) 0.0509 0.5986 1.856(0.983–3.505) 0.0564 0.6398
rs4506565 TCF7L2 T*/A 0.0467 0.0370 1.273(1.072–1.511) 0.0057 0.0903 1.318(1.097–1.584) 0.0032 0.0532
rs17271305 VPS13C G*/A 0.1607 0.1556 1.039(0.942–1.145) 0.4475 0.9999 1.067(0.961–1.184) 0.2278 0.9877
rs2191349 DGKB T*/G 0.6643 0.6555 1.040(0.968–1.117) 0.2863 0.9957 1.048(0.970–1.131) 0.2364 0.9898
rs7944584 MADD A*/T 0.9784 0.9651 1.637(1.327–2.020) 3.5610
26 0.0002 1.624(1.294–2.038) 2.9610
25 0.0006
rs10885122 ADRA2A G*/T 0.9237 0.9197 1.057(0.931–1.198) 0.3923 0.9998 1.073(0.936–1.229) 0.3119 0.9989
rs174550 FADS1 T*/C 0.5919 0.5787 1.056(0.985–1.131) 0.1215 0.8887 1.039(0.965–1.119) 0.3066 0.9988
rs11605924 CRY2 C/A* 0.2449 0.2303 1.084(1.000–1.174) 0.0487 0.5821 1.078(0.989–1.176) 0.0882 0.8028
rs11920090 SLC2A2 A/T* 0.0114 0.0092 1.249(0.889–1.754) 0.1984 0.9741 1.407(0.975–2.031) 0.0679 0.7074
rs7034200 GLIS3 A*/C 0.4489 0.4247 1.103(1.028–1.184) 0.0062 0.0961 1.120(1.038–1.209) 0.0037 0.0630
rs340874 PROX1 C*/T 0.3918 0.3778 1.061(0.989–1.137) 0.0984 0.8166 1.082(1.004–1.166) 0.0391 0.5063
rs11071657 C2CD4B G/A* 0.3703 0.3679 1.010(0.942–1.084) 0.7710 1 1.036(0.962–1.116) 0.3485 0.9994
rs11558471 SLC30A8 A*/G 0.5969 0.5487 1.218(1.137–1.305) 2.0610
28 0.0001 1.263(1.172–1.361) 1.1610
29 0.0001
rs35767 IGF1 A/G* 0.3420 0.3362 1.027(0.956–1.103) 0.4724 0.9999 1.017(0.940–1.099) 0.6813 1
*risk allele for type 2 diabetes in the European descent population.
#adjusted for age, gender and BMI.
P values,0.05 were shown in bold.
doi:10.1371/journal.pone.0015542.t002
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SNP Gene
Effect allele*/
other allele
Fasting glucose
(n=3,312)
2-h glucose
(n=3,312)
Fasting insulin
(n=2,309)
2-h insulin
(n=2,295)
rs10423928 GIPR A/T Beta 20.0118 20.0185 0.0074 20.0061
(95%CI) (20.0428–0.0191) (20.0868–0.0497) (20.0115–0.0263) (20.0318–0.0197)
P 0.4536 0.5951 0.4445 0.6450
rs2877716 ADCY5 C/T Beta 20.0190 20.0528 0.0657 20.0457
(95%CI) (20.2637–0.2256) (20.5908–0.4852) (20.1071–0.2385) (20.2814–0.1899)
P 0.8788 0.8476 0.4562 0.7038
rs11708067 ADCY5 A/G Beta 0.0736 0.0421 20.0323 20.0126
(95%CI) (20.1452–0.2925) (20.4400–0.5242) (20.1679–0.1032) (20.1978–0.1725)
P 0.5097 0.8642 0.6403 0.8936
rs12243326 TCF7L2 C/T Beta 20.0780 0.0306 0.0772 20.0833
(95%CI) (20.3081–0.1521) (20.4764–0.5376) (20.0642–0.2184) (20.2748–0.1082)
P 0.5065 0.9058 0.2847 0.3937
rs4506565 TCF7L2 T/A Beta 0.0209 0.0682 0.0108 0.0078
(95%CI) (20.0423–0.0842) (20.0711–0.2074) (20.0275–0.0491) (20.0443–0.0599)
P 0.5165 0.3375 0.5811 0.7684
rs17271305 VPS13C G/A Beta 0.0236 20.0003 0.0048 0.0038
(95%CI) (20.0098–0.0571) (20.0741–0.0735) (20.0159–0.0255) (20.0244–0.0319)
P 0.1666 0.9936 0.6492 0.7934
rs2191349 DGKB T/G Beta 0.0335 0.0099 20.0025 20.0168
(95%CI) (0.0085–0.0585) (20.0452–0.0650) (20.0177–0.0128) (20.0375–0.0040)
P 0.0086 0.7250 0.7524 0.1140
rs7944584 MADD A/T Beta 0.0673 0.0483 20.0045 20.0006
(95%CI) (0.0034–0.1312) (20.0926–0.1892) (20.0440–0.0349) (20.0545–0.0532)
P 0.0392 0.5014 0.8221 0.9813
rs10885122 ADRA2A G/T Beta 0.0010 0.0014 0.0033 0.0070
(95%CI) (20.0420–0.0440) (20.0936–0.0965) (20.0221–0.0288) (20.0277–0.0416)
P 0.9638 0.9765 0.7963 0.6939
rs174550 FADS1 T/C Beta 0.0149 20.0364 20.0095 0.0017
(95%CI) (20.0093–0.0390) (20.0896–0.0169) (20.0240–0.0051) (20.0182–0.0216)
P 0.2270 0.1808 0.2018 0.8696
rs11605924 CRY2 A/C Beta 20.0057 20.0596 20.0061 20.0304
(95%CI) (20.0338–0.0224) (20.1214–0.0021) (20.0234–0.0112) (20.054120.0068)
P 0.6891 0.0586 0.4915 0.0117
rs11920090 SLC2A2 T/A Beta 0.0193 20.0239 20.0174 0.0529
(95%CI) (20.1068–0.1454) (20.3016–0.2537) (20.0944–0.0596) (20.0518–0.1576)
P 0.7643 0.8658 0.6587 0.3220
rs7034200 GLIS3 A/C Beta 0.0090 0.0157 20.0099 0.0012
(95%CI) (20.0153–0.0333) (20.0380–0.0693) (20.0247–0.0049) (20.0189–0.0213)
P 0.4658 0.5675 0.1900 0.9078
rs340874 PROX1 C/T Beta 0.0200 0.0879 0.0069 20.0010
(95%CI) (20.0045–0.0444) (0.0341–0.1416) (20.0078–0.0217) (20.0212–0.0192)
P 0.1097 0.0014 0.3577 0.9244
rs11071657 C2CD4B A/G Beta 0.0039 0.0002 20.0029 20.0040
(95%CI) (20.0204–0.0281) (20.0533–0.0537) (20.0177–0.0119) (20.0242–0.0163)
P 0.7550 0.9943 0.7024 0.7016
rs11558471 SLC30A8 A/G Beta 0.0376 20.0199 20.0036 20.0131
(95%CI) (0.0139–0.0614) (20.0722–0.0324) (20.0181–0.0108) (20.0328–0.0067)
P 0.0019 0.4562 0.6215 0.1941
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or OGTT 2-h glucose levels [7,8]. The SNPs were genotyped by
using primer extension of multiplex products with detection by
matrix-assisted laser desorption ionization – time of flight mass
spectroscopy using a MassARRAY Compact Analyzer (Seque-
nom, San Diego, CA, USA). All seventeen SNPs passed genotype
quality control analyses.
Statistical analysis
The Hardy-Weinberg equilibrium test was performed before
the association analysis. SNPs failed Hardy-Weinberg equilibrium
tests (p,0.01 in the controls) were excluded. The allelic
frequencies between the diabetic patients and controls were
compared using x
2 tests, and ORs with 95% CIs were presented.
As age, gender and BMI differed in the cases and controls, we
further adjusted them as confounding factors by logistic regression.
Quantitative traits were analyzed by linear regression adjusted for
age, gender and BMI under an additive genetic model. All skewly
distributed quantitative traits, including fasting and 2-h insulin
levels, HOMA-B, HOMA-IR, STUMVOLL and GUTT, were
logarithmically transformed (log10) to approximate univariate
normality (p.0.01 by Kolmogorov-Smirnov test). In order to
adjust multiple comparison, 10,000 permutations were performed
for each trait to assess empirical p values using PLINK [20]. The
statistical analyses were performed using SAS for Windows
(version 8.0; SAS Institute, Cary, NC, USA) unless specified
otherwise. A two-tailed p value of ,0.05 was considered
statistically significant.
The statistic power was estimated under an additive genetic
model based on the previously reported effect size and allele
frequency observed in our samples. For SNPs with minor allele
frequency over 0.2, our sample size had over 80% power to detect
an effect size of 0.035 mmol/l for fasting glucose, 0.10 mmol/l for
2-h glucose and an OR of 1.13 for type 2 diabetes risk. For SNPs
with minor allele frequency equal to 0.05, our sample size had
over 80% power to detect an effect size of 0.08 mmol/l for fasting
glucose, 0.17 mmol/l for 2-h glucose and an OR of 1.24 for type 2
diabetes risk.
Results
All SNPs were in accordance with Hardy-Weinberg equilibri-
um. Table 2 showed the analyses of associations between these
SNPs and type 2 diabetes. GIPR rs10423928 (OR 1.097, 95%CI
1.005–1.197, p=0.0378), TCF7L2 rs4506565 (OR 1.273, 95%CI
1.072–1.511, p=0.0057), MADD rs7944584 (OR 1.637, 95%CI
1.327–2.020, p=3.5610
26), CRY2 rs11605924 (OR 1.084,
95%CI 1.000–1.174, p=0.0487), GLIS3 rs7034200 (OR 1.103,
95%CI 1.028–1.184, p=0.0062) and SLC30A8 rs11558471 (OR
1.218, 95%CI 1.137–1.305, p=2.0610
28) were associated with
type 2 diabetes. And PROX1 rs340874 showed a trend towards
association to type 2 diabetes in our samples (OR 1.061, 95%CI
0.989–1.137, p=0.0984). However, after correction of multiple
comparisons by 10,000 permutations, only the effects of MADD
rs7944584 and SLC30A8 rs11558471 on type 2 diabetes remained
to be significant (empirical p=0.0002 and 0.0001, respectively).
We also tested the effects of these SNPs after adjusting for age,
gender and BMI as confounding factors as they differed
significantly between cases and controls. Most of the SNPs showed
similar effects with or without adjustment, but the association
between CRY2 rs11605924 and type 2 diabetes was lost (OR
1.078, 95%CI 0.989–1.176, p=0.0882) while PROX1 rs340874
showed a significant association to type 2 diabetes (OR 1.082,
95%CI 1.004–1.166, p=0.0391).
We then analyzed the effects of these SNPs on quantitative traits
in the controls. As shown in Table 3 and Table 4, SNPs from
DGKB, MADD and SLC30A8 were significantly associated with
fasting glucose (p=0.0086, 0.0392 and 0.0019; empirical
p=0.1337, 0.4833 and 0.0329; respectively) while PROX1
rs340874 was significantly associated with OGTT 2-h glucose
(p=0.0014; empirical p=0.0232). The glucose-raising allele of
these loci showed association to lower insulin secretion index
Stumvoll (p=0.0237, 0.0330, 0.0482 and 0.0333; empirical
p=0.3290, 0.4234, 0.5624 and 0.4272). For insulin levels, IGF1
rs35767 showed significant association to both fasting and 2-h
insulin levels (p=0.0153 and 0.0073; empirical p=0.2351 and
0.1105) as well as insulin secretion and sensitivity indices HOMA-
B, HOMA-IR and Gutt (p=0.0133, 0.0160 and 0.0035; empirical
p=0.1997, 0.2465 and 0.0626), while CRY2 rs11605924 was
associated with 2-h insulin levels and Gutt (p=0.0117 and 0.0103;
empirical p=0.1727 and 0.1660). However, SNPs from GIPR,
ADCY5, TCF7L2, VPS13C, ADRA2A, FADS1, SLC2A2, GLIS3 and
C2CD4B showed no association to any quantitative trait of glucose
metabolism in our samples.
Discussion
In the current study, we tried to replicate the effects of recently
reported loci influencing quantitative traits related to glucose
metabolism in a Shanghai Chinese population. To our knowledge,
this is the first replication study in Asian population focusing on
these loci up to now. We confirmed the association between
DGKB, MADD and SLC30A8 and fasting glucose. We also found
PROX1 was associated with 2-h glucose in our samples. The effects
of IGF1 rs35767 on fasting insulin and insulin sensitivity were also
observed. However, the direction of effects was opposite to that
observed in the European descent samples [7,21]. It should also be
noted that the allele frequencies of rs35767 differed between
European and Chinese populations (0.15 vs 0.35 for A allele). It
suggests causal variant within this locus remained to be identified.
SNP Gene
Effect allele*/
other allele
Fasting glucose
(n=3,312)
2-h glucose
(n=3,312)
Fasting insulin
(n=2,309)
2-h insulin
(n=2,295)
rs35767 IGF1 G/A Beta 20.0101 20.0215 20.0191 20.0290
(95%CI) (20.0353–0.0152) (20.0772–0.0342) (20.034620.0037) (20.050120.0078)
P 0.4343 0.4490 0.0153 0.0073
P values,0.05 were shown in bold. P values were adjusted for age, gender and BMI.
Log transformed (log10) values were used for fasting and 2-h insulin levels.
*Effect allele referred to the allele for higher glucose or insulin levels reported in the European descents.
doi:10.1371/journal.pone.0015542.t003
Table 3. Cont.
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SNP Gene
Effect allele*/
other allele HOMA-B (n=2,302) STUMVOLL (n=2,303) HOMA-IR (n=2,309) GUTT (n=2,291)
rs10423928 GIPR A/T Beta 0.0082 0.0048 0.0067 0.0033
(95%CI) (20.0135–0.0299) (20.0046–0.0142) (20.0129–0.0263) (20.0076–0.0141)
P 0.4594 0.3186 0.5035 0.5547
rs2877716 ADCY5 C/T Beta 20.0105 20.0375 0.0820 20.0033
(95%CI) (20.2088–0.1877) (20.1236–0.0486) (20.0972–0.2613) (20.1026–0.0960)
P 0.9170 0.3931 0.3699 0.9479
rs11708067 ADCY5 A/G Beta 20.1094 20.0402 20.0149 20.0065
(95%CI) (20.2648–0.0460) (20.1078–0.0274) (20.1556–0.1257) (20.0845–0.0716)
P 0.1678 0.2439 0.8352 0.8713
rs12243326 TCF7L2 C/T Beta 0.0273 20.0127 0.0870 0.0146
(95%CI) (20.1346–0.1892) (20.0829–0.0576) (20.0594–0.2335) (20.0663–0.0955)
P 0.7412 0.7238 0.2442 0.7235
rs4506565 TCF7L2 T/A Beta 20.0113 20.0142 0.0167 20.0077
(95%CI) (20.0553–0.0327) (20.0333–0.0050) (20.0231–0.0564) (20.0296–0.0142)
P 0.6144 0.1482 0.4116 0.4895
rs17271305 VPS13C G/A Beta 0.0001 20.0043 0.0061 20.0053
(95%CI) (20.0236–0.0238) (20.0145–0.0060) (20.0153–0.0275) (20.0172– 0.0066)
P 0.9952 0.4160 0.5768 0.3861
rs2191349 DGKB T/G Beta 20.0142 20.0087 0.0007 0.0026
(95%CI) (20.0317–0.0034) (20.016320.0012) (20.0151–0.0165) (20.0062–0.0113)
P 0.1130 0.0237 0.9305 0.5672
rs7944584 MADD A/T Beta 20.0410 20.0214 0.0053 20.0043
(95%CI) (20.0863–0.0043) (20.041120.0017) (20.0356–0.0462) (20.0270–0.0183)
P 0.0763 0.0330 0.7991 0.7085
rs10885122 ADRA2A G/T Beta 0.0149 0.0056 0.0008 0.0008
(95%CI) (20.0143–0.0442) (20.0071–0.0182) (20.0255–0.0271) (20.0139–0.0154)
P 0.3175 0.3888 0.9529 0.9185
rs174550 FADS1 T/C Beta 20.0125 20.0007 20.0084 0.0020
(95%CI) (20.0292–0.0042) (20.0079–0.0066) (20.0235–0.0066) (20.0064–0.0104)
P 0.1429 0.8537 0.2736 0.6397
rs11605924 CRY2 A/C Beta 20.0109 20.0024 20.0047 0.0130
(95%CI) (20.0308–0.0091) (20.0111–0.0063) (20.0227–0.0133) (0.0031 2 0.0230)
P 0.2851 0.5867 0.6073 0.0103
rs11920090 SLC2A2 T/A Beta 20.0154 20.0095 20.0168 20.0151
(95%CI) (20.1037–0.0729) (20.0478–0.0287) (20.0967–0.0631) (20.0593–0.0291)
P 0.7324 0.6253 0.6801 0.5034
rs7034200 GLIS3 A/C Beta 20.0072 20.0025 20.0098 20.0009
(95%CI) (20.0242–0.0097) (20.0099–0.0048) (20.0252–0.0056) (20.0094–0.0076)
P 0.4030 0.5020 0.2116 0.8364
rs340874 PROX1 C/T Beta 20.0013 20.0080 0.0089 20.0045
(95%CI) (20.0183–0.0158) (20.015420.0006) (20.0064–0.0242) (0.0130–0.0040)
P 0.8855 0.0333 0.2551 0.3003
rs11071657 C2CD4B A/G Beta 20.0060 20.0008 20.0024 0.0018
(95%CI) (20.0231–0.0111) (20.0082–0.0066) (20.0177–0.0130) (20.0067–0.0104)
P 0.4920 0.8285 0.7620 0.6750
rs11558471 SLC30A8 A/G Beta 20.0205 20.0073 0.0006 0.0050
(95%CI) (20.0371–0.0038) (20.014520.0001) (20.0144–0.0156) (20.0034–0.0133)
P 0.0162 0.0482 0.9408 0.2420
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MADD, CRY2, GLIS3, PROX1 and SLC30A8, had an effect on type
2 diabetes in our samples. Most of these associations were in
consistence with findings in the European descent samples, except
that MADD rs7944584 showed an association to type 2 diabetes
only in the Chinese samples. MADD encodes mitogen-activated
protein kinase activating death domain, which interacted with
tumor necrosis factor alpha receptor 1 to activate mitogen-
activated protein kinase and propagate the apoptotic signal [22].
Previous study in European samples showed the glucose-raising
allele of MADD rs7944584 was associated with elevated fasting
proinsulin without altering insulin secretion [21], suggesting this
locus was associated with insulin processing defects. In this study,
we found the glucose-raising allele was associated with a higher
risk for type 2 diabetes in the Chinese population. The underlying
mechanism is not clear, but it is known the defects in insulin
processing may lead to endothelium reticulum stress and finally
beta cell dysfunction [23]. However, this SNP showed a negligible
effect on type 2 diabetes in the European population. It is not clear
whether ethnic difference played a role in the effect of this locus as
poor insulin compensation ability was observed in the Asians
compared with the European descent populations [24]. On the
other hand, we cannot exclude the possibility that the effect of
MADD rs7944584 on type2 diabetes was over estimated or even
this association was just a positive finding by chance. Thus further
replication studies in the Asian samples are needed.
In this study, we failed to replicate the associations of several
variants with fasting or 2-h glucose levels. Some of these un-
replicated SNPs including the ones from ADCY5, TCF7L2,
SLC2A2 and ADRA2A were much rarer in the Asians than they
were in the European descent populations (e.g., ADCY5, with
minor allele frequency 0.002 in the Chinese vs 0.25 in the
European descents). We may not have enough statistical power to
replicate the effects of some loci because of the smaller minor allele
frequency. Whether there are common SNPs at these loci with
effects on glucose metabolism in the Asians are unknown and
remain to be investigated. There are also some SNPs lacking
replication because of the smaller effect size (e.g. C2CD4B, with
reported beta=0.008 mmol/l per allele). However, there are still
loci that failed to be replicated in our samples even though we had
enough statistical power, e.g. GIPR, which suggests heterogeneous
effects of these loci may exist in the Chinese comparing with
European descent populations.
Although we analyzed these loci in relatively large samples,
there are several limitations of our study. First, as multiple traits
and SNPs were analyzed in the current study, we could not
exclude the possibility that our findings were false positive. But
considering these SNPs were originally identified in large-scale
genome-wide association studies and all the traits analyzed were
highly related, the impact of multiple comparisons may be limited.
Second, we only analyzed the effects of these loci on insulin
sensitivity and secretion in the normal glucose regulation subjects
as most of the type 2 diabetes patients were receiving glucose
lowering therapy. However, Heni et al showed the impact of
genetic variation on insulin secretion depends on glycaemia
[25,26], what are the effects of these variants in the diabetic
patients and prediabetes subjects remained unknown and to be
investigated. Third, only the reported SNP(s) from each locus was
analyzed in the current study. As differences exist in allele
frequencies as well as linkage disequilibrium structure between
Asians and European populations, detailed analyzing of more
SNPs from each locus in Asian samples may help identify the
causal variant.
In conclusion, we analyzed the effects of SNPs from fifteen loci
recently reported to be associated with fasting and/or 2-h glucose
or fasting insulin in the Chinese samples, and showed SNPs from
GIPR, TCF7L2, DGKB, MADD, CRY2, GLIS3, PROX1, SLC30A8
and IGF1 were associated with traits related to glucose metabolism
in the Chinese population. Moreover, our data suggest heteroge-
neous effects of SNPs from MADD and GIPR may exist in the
Chinese population comparing with European population.
Acknowledgments
We thank all the participants of this research. We thank all nursing and
medical staff at Shanghai Clinical Center for Diabetes for their dedication
in this study.
Author Contributions
Conceived and designed the experiments: WJ KX CH. Performed the
experiments: CH RZ CW JL WY FJ. Analyzed the data: CH. Contributed
reagents/materials/analysis tools: XM XH YB. Wrote the paper: CH JW.
References
1. Yang W, Lu J, Weng J, Jia W, Ji L, et al. (2010) Prevalence of diabetes among
men and women in China. N Engl J Med 362: 1090–1101.
2. Stumvoll M, Goldstein BJ, van Haeften TW (2005) Type 2 diabetes: principles of
pathogenesis and therapy. Lancet 365: 1333–1346.
3. Bouatia-Naji N, Rocheleau G, Van Lommel L, Lemaire K, Schuit F, et al.
(2008) A polymorphism within the G6PC2 gene is associated with fasting plasma
glucose levels. Science 320: 1085–1088.
4. Florez JC (2008) Clinical review: the genetics of type 2 diabetes: a realistic
appraisal in 2008. J Clin Endocrinol Metab 93: 4633–4642.
5. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, et al. (2009)
Variants in MTNR1B influence fasting glucose levels. Nat Genet 41: 77–81.
6. Tsai FJ, Yang CF, Chen CC, Chuang LM, Lu CH, et al. A genome-wide
association study identifies susceptibility variants for type 2 diabetes in Han
Chinese. PLoS Genet 6: e1000847.
SNP Gene
Effect allele*/
other allele HOMA-B (n=2,302) STUMVOLL (n=2,303) HOMA-IR (n=2,309) GUTT (n=2,291)
rs35767 IGF1 G/A Beta 20.0225 20.0033 20.0197 0.0133
(95%CI) (20.040420.0047) (20.0110–0.0044) (20.035720.0037) (0.0044–0.0222)
P 0.0133 0.3998 0.0160 0.0035
P values,0.05 were shown in bold. P values were adjusted for age, gender and BMI.
Log transformed (log10) values were used for HOMA-B, STUMVOLL, HOMA-IR and GUTT.
*Effect allele referred to the allele for higher glucose or insulin levels reported in the European descents.
doi:10.1371/journal.pone.0015542.t004
Table 4. Cont.
Glucose and Insulin Loci in Chinese
PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e155427. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New
genetic loci implicated in fasting glucose homeostasis and their impact on type 2
diabetes risk. Nat Genet 42: 105–116.
8. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, et al. (2010)
Genetic variation in GIPR influences the glucose and insulin responses to an oral
glucose challenge. Nat Genet 42: 142–148.
9. Takeuchi F, Katsuya T, Chakrewarthy S, Yamamoto K, Fujioka A, et al. (2010)
Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci
are associated with fasting glucose in two Asian populations. Diabetologia 53:
299–308.
10. Hu C, Zhang R, Wang C, Yu W, Lu J, et al. (2010) The effects of GCK, GCKR,
G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
PLoS ONE 5: e11761.
11. Hu C, Zhang R, Wang C, Ma X, Wang C, et al. (2009) A genetic variant of
G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the
Chinese population. Diabetologia 52: 451–456.
12. Tam CH, Ho JS, Wang Y, Lee HM, Lam VK, et al. Common polymorphisms
in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma
glucose and impaired beta-cell function in Chinese subjects. PLoS One 5:
e11428.
13. Liu C, Wu Y, Li H, Qi Q, Langenberg C, et al. (2010) MTNR1B rs10830963 is
associated with fasting plasma glucose, HbA1C and impaired beta-cell function
in Chinese Hans from Shanghai. BMC Med Genet 11: 59.
14. Ronn T, Wen J, Yang Z, Lu B, Du Y, et al. (2009) A common variant in
MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes
and fasting plasma glucose in Han Chinese individuals. Diabetologia 52:
830–833.
15. Jia WP, Pang C, Chen L, Bao YQ, Lu JX, et al. (2007) Epidemiological
characteristics of diabetes mellitus and impaired glucose regulation in a Chinese
adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-
up study in Shanghai urban communities. Diabetologia 50: 286–292.
16. Bao Y, Ma X, Li H, Zhou M, Hu C, et al. (2010) Glycated haemoglobin A1c for
diagnosing diabetes in Chinese population: cross sectional epidemiological
survey. BMJ 340: c2249.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985)
Homeostasis model assessment: insulin resistance and beta-cell function from
fasting plasma glucose and insulin concentrations in man. Diabetologia 28:
412–419.
18. Stumvoll M, Van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance
test indexes for insulin sensitivity and secretion based on various availabilities of
sampling times. Diabetes Care 24: 796–797.
19. Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, et al. (2000) Validation
of the insulin sensitivity index (ISI(0,120)): comparison with other measures.
Diabetes Res Clin Pract 47: 177–184.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007)
PLINK: a tool set for whole-genome association and population-based linkage
analyses. Am J Hum Genet 81: 559–575.
21. Ingelsson E, Langenberg C, Hivert MF, Prokopenko I, Lyssenko V, et al. (2010)
Detailed physiologic characterization reveals diverse mechanisms for novel
genetic Loci regulating glucose and insulin metabolism in humans. Diabetes 59:
1266–1275.
22. Kurada BR, Li LC, Mulherkar N, Subramanian M, Prasad KV, et al. (2009)
MADD, a splice variant of IG20, is indispensable for MAPK activation and
protection against apoptosis upon tumor necrosis factor-alpha treatment. J Biol
Chem 284: 13533–13541.
23. Scheuner D, Kaufman RJ (2008) The unfolded protein response: a pathway that
links insulin demand with beta-cell failure and diabetes. Endocr Rev 29:
317–333.
24. Torrens JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, et al. (2004)
Ethnic differences in insulin sensitivity and beta-cell function in premenopausal
or early perimenopausal women without diabetes: the Study of Women’s Health
Across the Nation (SWAN). Diabetes Care 27: 354–361.
25. Heni M, Ketterer C, t Hart LM, Ranta F, van Haeften TW, et al. The Impact of
Genetic Variation in the G6PC2 Gene on Insulin Secretion Depends on
Glycemia. J Clin Endocrinol Metab.
26. Heni M, Ketterer C, Thamer C, Herzberg-Schafer SA, Guthoff M, et al.
Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion.
Diabetes.
Glucose and Insulin Loci in Chinese
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e15542